Your browser doesn't support javascript.
loading
Automatically detecting Crohn's disease and Ulcerative Colitis from endoscopic imaging.
Chierici, Marco; Puica, Nicolae; Pozzi, Matteo; Capistrano, Antonello; Donzella, Marcello Dorian; Colangelo, Antonio; Osmani, Venet; Jurman, Giuseppe.
Affiliation
  • Chierici M; Fondazione Bruno Kessler, via Sommarive, 18, 38123, Trento, Italy. chierici@fbk.eu.
  • Puica N; PagoPA S.p.A., Rome, Italy.
  • Pozzi M; Fondazione Bruno Kessler, via Sommarive, 18, 38123, Trento, Italy.
  • Capistrano A; Università degli studi di Trento, via Calepina, 14, 38122, Trento, Italy.
  • Donzella MD; GPI S.p.A., via Ragazzi del '99, 13, 38123, Trento, Italy.
  • Colangelo A; GPI S.p.A., via Ragazzi del '99, 13, 38123, Trento, Italy.
  • Osmani V; GPI S.p.A., via Ragazzi del '99, 13, 38123, Trento, Italy.
  • Jurman G; Fondazione Bruno Kessler, via Sommarive, 18, 38123, Trento, Italy.
BMC Med Inform Decis Mak ; 22(Suppl 6): 300, 2022 11 18.
Article in En | MEDLINE | ID: mdl-36401328
ABSTRACT

BACKGROUND:

The SI-CURA project (Soluzioni Innovative per la gestione del paziente e il follow up terapeutico della Colite UlceRosA) is an Italian initiative aimed at the development of artificial intelligence solutions to discriminate pathologies of different nature, including inflammatory bowel disease (IBD), namely Ulcerative Colitis (UC) and Crohn's disease (CD), based on endoscopic imaging of patients (P) and healthy controls (N).

METHODS:

In this study we develop a deep learning (DL) prototype to identify disease patterns through three binary classification tasks, namely (1) discriminating positive (pathological) samples from negative (healthy) samples (P vs N); (2) discrimination between Ulcerative Colitis and Crohn's Disease samples (UC vs CD) and, (3) discrimination between Ulcerative Colitis and negative (healthy) samples (UC vs N).

RESULTS:

The model derived from our approach achieves a high performance of Matthews correlation coefficient (MCC) > 0.9 on the test set for P versus N and UC versus N, and MCC > 0.6 on the test set for UC versus CD.

CONCLUSION:

Our DL model effectively discriminates between pathological and negative samples, as well as between IBD subgroups, providing further evidence of its potential as a decision support tool for endoscopy-based diagnosis.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis, Ulcerative / Crohn Disease Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis, Ulcerative / Crohn Disease Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article